Neuropace, Inc. NPCE Deferred Tax Assets, Operating Loss Carryforwards
Deferred Tax Assets, Operating Loss Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax assets, operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax assets, operating loss carryforwards?
- Neuropace, Inc. (NPCE) reported deferred tax assets, operating loss carryforwards of $46.03M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax assets, operating loss carryforwards changed year-over-year?
- Neuropace, Inc.'s deferred tax assets, operating loss carryforwards increased by 9.5% year-over-year, from $42.04M to $46.03M.
- What is the long-term trend for Neuropace, Inc.'s deferred tax assets, operating loss carryforwards?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s deferred tax assets, operating loss carryforwards has grown at a 8.7% compound annual growth rate (CAGR), from $30.37M to $46.03M.